Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Concurrent Doses of BIA 5-1058 and Furosemide [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics, safety and tolerability of concurrent dosing of BIA 5-1058 with furosemide in pulmonary arterial hypertension; the up…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• BIA 5-1058
• FUROSEMIDE (Furosemide)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: COMPLETED